Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END-USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTERS FIVE FORCES ANALYSIS
4.2 BRAND OUTLOOK
4.2.1 BRAND COMPARATIVE ANALYSIS OF KEY NORTH AMERICA PLAYERS
4.2.1.1 BRAND COMPARATIVE NARRATIVE (ANALYTICAL OVERVIEW)
4.2.2 PRODUCT VS BRAND OVERVIEW — NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET
4.2.2.1 PRODUCT OVERVIEW — ENDOSCOPIC HEMOSTASIS DEVICES
4.2.2.2 BRAND OVERVIEW — INFLUENCE ON NORTH AMERICA CLINICAL ADOPTION
4.3 CONSUMER BUYING BEHAVIOUR
4.3.1 CLINICAL EFFECTIVENESS AND PATIENT OUTCOMES
4.3.2 COST AND VALUE CONSIDERATIONS
4.3.3 COMPATIBILITY AND INTEGRATION
4.3.4 TRAINING REQUIREMENTS AND EASE OF USE
4.3.5 REIMBURSEMENT AND HEALTHCARE POLICY ALIGNMENT
4.3.6 PROCUREMENT PROCESSES AND BULK AGREEMENTS
4.3.7 INFLUENCE OF CLINICAL STAKEHOLDERS
4.3.8 TRENDS IN BUYER BEHAVIOUR
4.3.9 CONCLUSION
4.4 PATENT ANALYSIS
4.4.1 PATENT QUALITY AND STRENGTH – NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET
4.4.2 COUNTRY PATENT LANDSCAPE
4.4.3 IP STRATEGY AND MANAGEMENT
4.4.4 LICENSING AND COLLABORATION
4.5 RAW MATERIAL COVERAGE
4.5.1 METALLIC COMPONENTS AND ALLOY SYSTEMS
4.5.2 POLYMERIC AND SYNTHETIC MATERIALS
4.5.3 NATURAL AND BIOCOMPATIBLE MATERIALS
4.5.4 ELECTRICAL AND THERMAL MATERIAL SYSTEMS
4.5.5 EXPENDABLE ACCESSORIES AND SINGLE-USE MATERIALS
4.6 TECHNOLOGICAL ADVANCEMENTS IN NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET
4.6.1 ENHANCED MECHANICAL HEMOSTASIS TOOLS
4.6.2 ADVANCED THERMAL COAGULATION AND ENERGY-BASED SYSTEMS
4.6.3 NOVEL TOPICAL HEMOSTATIC AGENTS
4.6.4 INTEGRATION WITH ADJUNCTIVE DIAGNOSTIC TECHNOLOGIES
4.6.5 DEVELOPMENT OF MULTIFUNCTIONAL AND COMBINATION DEVICES
4.6.6 IMPROVED USER ERGONOMICS AND DEVICE DEPLOYMENT SYSTEMS
4.6.7 CONCLUSION
4.7 VALUE CHAIN ANALYSIS
4.7.1 OVERVIEW
4.7.2 RAW MATERIALS & COMPONENTS
4.7.3 DEVICE DESIGN, R&D & MANUFACTURING
4.7.4 PROCESSING, FINISHING & STERILIZATION
4.7.5 PACKAGING & LABELING
4.7.6 LOGISTICS, DISTRIBUTION & COMMERCIALIZATION
4.7.7 CONCLUSION
4.8 VENDOR SELECTION CRITERIA
4.8.1 CLINICAL PERFORMANCE
4.8.2 REGULATORY COMPLIANCE AND APPROVALS
4.8.3 COST AND TOTAL VALUE PROPOSITION
4.8.4 SUPPLY CHAIN ROBUSTNESS AND LOGISTICS
4.8.5 SUPPORT, TRAINING AND CLINICAL EDUCATION
4.8.6 QUALITY SYSTEMS AND REPROCESSING GUIDANCE
4.8.7 REPUTATION, PEER ACCEPTANCE AND POST-MARKET PERFORMANCE
4.8.8 INNOVATION AND FUTURE-READINESS
4.9 COMPANY EVALUATION QUADRANT
4.1 PROFIT MARGIN SCENARIO
4.10.1 MARGIN IMPROVEMENT DRIVERS
4.10.2 COST PRESSURE
4.10.3 REGIONAL VARIATIONS
4.10.4 FUTURE SCENARIOS
4.11 CLIMATE CHANGE SCENARIO
4.11.1 ENVIRONMENTAL CONCERNS
4.11.2 INDUSTRY RESPONSE
4.11.3 GOVERNMENT’S ROLE
4.11.4 ANALYST RECOMMENDATIONS
4.12 INNOVATION TRACKER AND STRATEGIC ANALYSIS
4.12.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
4.12.1.1 JOINT VENTURES
4.12.1.2 MERGERS AND ACQUISITIONS
4.12.1.3 LICENSING AND PARTNERSHIP
4.12.1.4 TECHNOLOGY COLLABORATIONS
4.12.2 STRATEGIC DIVESTMENTS
4.12.3 STAGE OF DEVELOPMENT
4.12.4 TIMELINES AND MILESTONES
4.12.5 INNOVATION STRATEGIES AND METHODOLOGIES
4.12.6 RISK ASSESSMENT AND MITIGATION
4.12.7 FUTURE OUTLOOK
4.13 PRICING ANALYSIS
4.13.1 HEMOSTATIC CLIPS AND FORCEPS PRICING
4.13.2 BANDING AND COAGULATION DEVICES
4.13.3 REGULATORY AND REIMBURSEMENT IMPACT
4.14 SUPPLY CHAIN ANALYSIS
4.14.1 OVERVIEW
4.14.2 LOGISTIC COST SCENARIO
4.14.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
4.14.4 CONCLUSION
5 TARIFFS & IMPACT ON THE MARKET
5.1 OVERVIEW
5.2 CURRENT TARIFF RATE (S) IN TOP-5 COUNTRY MARKETS
5.3 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE
5.4 VENDOR SELECTION CRITERIA
5.5 IMPACT ON SUPPLY CHAIN
5.5.1 RAW MATERIAL PROCUREMENT
5.5.2 MANUFACTURING AND PRODUCTION
5.5.3 LOGISTICS AND DISTRIBUTION
5.5.4 PRICE PITCHING AND POSITION OF MARKET
5.6 INDUSTRY PARTICIPANTS: PROACTIVE MOVES
5.6.1 SUPPLY CHAIN OPTIMIZATION
5.6.2 JOINT VENTURE ESTABLISHMENTS
5.7 IMPACT ON PRICES
5.8 REGULATORY INCLINATION
5.8.1 GEOPOLITICAL SITUATION
5.8.2 TRADE PARTNERSHIPS BETWEEN THE COUNTRIES
5.8.2.1 FREE TRADE AGREEMENTS
5.8.2.2 ALLIANCES ESTABLISHMENTS
5.8.3 STATUS ACCREDITATION (INCLUDING MFTN)
5.8.4 DOMESTIC COURSE OF CORRECTION
5.8.4.1 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS
5.8.4.2 ESTABLISHMENT OF SEZS/INDUSTRIAL PARKS
6 REGULATION COVERAGE
6.1 PRODUCT CODES
6.2 CERTIFIED STANDARDS
6.3 SAFETY STANDARDS
6.3.1 MATERIAL HANDLING & STORAGE
6.3.2 TRANSPORT & PRECAUTIONS
6.3.3 HAZARD IDENTIFICATION
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISE IN GASTROINTESTINAL BLEEDING CASES
7.1.2 AGING POPULATION DRIVING INCREASED DEMAND FOR GI DISORDERS
7.1.3 ADOPTION OF MINIMALLY INVASIVE ENDOSCOPIC PROCEDURES
7.1.4 RISING AWARENESS AND EXPANDED SCREENING PROGRAMS FOR GASTROINTESTINAL ENDOSCOPY
7.2 RESTRAINTS
7.2.1 HIGH COST AND TECHNICAL COMPLEXITY OF ENDOSCOPIC HEMOSTASIS DEVICES
7.2.2 LIMITED AWARENESS IN LOW-INCOME COUNTRIES
7.3 OPPORTUNITIES
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEMOSTASIS DEVICES
7.3.2 EXPANSION IN EMERGING MARKETS (ASIA-PACIFIC, LATIN AMERICA)
7.3.3 GROWING ADOPTION OF HOME-BASED AND CAPSULE ENDOSCOPY SOLUTIONS
7.4 CHALLENGES
7.4.1 REIMBURSEMENT ISSUES FOR ENDOSCOPIC PROCEDURES
7.4.2 COMPLEXITIES IN ENDOSCOPE REPROCESSING AND STERILIZATION PROCESSES
8 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 MECHANICAL HEMOSTASIS DEVICES
8.2.1 MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
8.2.1.1 HEMOSTATIC CLIPS
8.2.1.1.1 HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE
8.2.1.1.1.1 THROUGH-THE-SCOPE (TTS) CLIPS
8.2.1.1.1.2 OVER-THE-SCOPE (OTS) CLIPS
8.2.1.1.2 HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL
8.2.1.1.2.1 STAINLESS STEEL
8.2.1.1.2.2 TITANIUM
8.2.1.2 BANDING DEVICES
8.2.1.2.1 BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE
8.2.1.2.1.1 VARICEAL BANDING KITS
8.2.1.2.1.2 OESOPHAGEAL BANDING DEVICES
8.2.1.3 HEMOSTATIC FORCEPS
8.2.1.4 OTHERS
8.2.2 MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
8.2.2.1 NORTH AMERICA
8.2.2.2 EUROPE
8.2.2.3 ASIA-PACIFIC
8.2.2.4 SOUTH AMERICA
8.2.2.5 MIDDLE EAST & AFRICA
8.3 THERMAL DEVICES
8.3.1 THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
8.3.1.1 ARGON PLASMA COAGULATORS
8.3.1.2 HEATER PROBES
8.3.1.3 BIPOLAR COAGULATION DEVICES
8.3.1.3.1 BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE
8.3.1.3.1.1 MONOPOLAR
8.3.1.3.1.2 BIPOLAR
8.3.1.3.2 BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION
8.3.1.3.2.1 UPPER GI BLEEDING
8.3.1.3.2.2 LOWER GI BLEEDING
8.3.1.4 OTHERS
8.3.2 THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
8.3.2.1 NORTH AMERICA
8.3.2.2 EUROPE
8.3.2.3 ASIA-PACIFIC
8.3.2.4 SOUTH AMERICA
8.3.2.5 MIDDLE EAST & AFRICA
8.4 TOPICAL AGENTS AND INJECTABLES
8.4.1 TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
8.4.1.1 EPINEPHRINE INJECTION
8.4.1.2 HEMOSTATIC SPRAY (POWDER)
8.4.1.3 HEMOSTATIC GELS
8.4.1.4 FIBRIN SEALANTS
8.4.1.5 SCLEROSING AGENTS
8.4.2 TOPICAL AGENTS AND INJECTABLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
8.4.2.1 NORTH AMERICA
8.4.2.2 EUROPE
8.4.2.3 ASIA-PACIFIC
8.4.2.4 SOUTH AMERICA
8.4.2.5 MIDDLE EAST & AFRICA
8.5 OTHERS
8.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
8.5.1.1 NORTH AMERICA
8.5.1.2 EUROPE
8.5.1.3 ASIA-PACIFIC
8.5.1.4 SOUTH AMERICA
8.5.1.5 MIDDLE EAST & AFRICA
9 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE TYPE
9.1 OVERVIEW
9.2 UPPER GASTROINTESTINAL ENDOSCOPY
9.2.1 UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
9.2.1.1 BLEEDING ULCER MANAGEMENT
9.2.1.2 VARICEAL BLEEDING
9.2.1.3 DIEULAFOY LESION
9.2.2 UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
9.2.2.1 NORTH AMERICA
9.2.2.2 EUROPE
9.2.2.3 ASIA-PACIFIC
9.2.2.4 SOUTH AMERICA
9.2.2.5 MIDDLE EAST & AFRICA
9.3 LOWER GASTROINTESTINAL ENDOSCOPY
9.3.1 LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
9.3.1.1 COLONIC BLEEDING
9.3.1.2 DIVERTICULAR BLEEDING
9.3.2 LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
9.3.2.1 NORTH AMERICA
9.3.2.2 EUROPE
9.3.2.3 ASIA-PACIFIC
9.3.2.4 SOUTH AMERICA
9.3.2.5 MIDDLE EAST & AFRICA
9.4 BRONCHOSCOPIC HEMOSTASIS
9.4.1 BRONCHOSCOPIC HEMOSTASIS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
9.4.1.1 NORTH AMERICA
9.4.1.2 EUROPE
9.4.1.3 ASIA-PACIFIC
9.4.1.4 SOUTH AMERICA
9.4.1.5 MIDDLE EAST & AFRICA
9.5 OTHERS
9.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
9.5.1.1 NORTH AMERICA
9.5.1.2 EUROPE
9.5.1.3 ASIA-PACIFIC
9.5.1.4 SOUTH AMERICA
9.5.1.5 MIDDLE EAST & AFRICA
10 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 GASTROINTESTINAL BLEEDING
10.2.1 GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
10.2.1.1 PEPTIC ULCER BLEEDING
10.2.1.2 ESOPHAGEAL VARICES
10.2.1.3 COLORECTAL CANCERS
10.2.2 GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE
10.2.2.1 MECHANICAL HEMOSTASIS DEVICES
10.2.2.2 THERMAL DEVICES
10.2.2.3 TOPICAL AGENTS AND INJECTABLES
10.2.2.4 OTHERS
10.2.3 GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
10.2.3.1 NORTH AMERICA
10.2.3.2 EUROPE
10.2.3.3 ASIA-PACIFIC
10.2.3.4 SOUTH AMERICA
10.2.3.5 MIDDLE EAST & AFRICA
10.3 NON-GASTROINTESTINAL BLEEDING
10.3.1 NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
10.3.1.1 NASAL BLEEDING (EPISTAXIS)
10.3.1.2 POST-SURGICAL BLEEDING
10.3.2 NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE
10.3.2.1 MECHANICAL HEMOSTASIS DEVICES
10.3.2.2 THERMAL DEVICES
10.3.2.3 TOPICAL AGENTS & INJECTABLES
10.3.2.4 OTHERS
10.3.3 NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
10.3.3.1 NORTH AMERICA
10.3.3.2 EUROPE
10.3.3.3 ASIA-PACIFIC
10.3.3.4 SOUTH AMERICA
10.3.3.5 MIDDLE EAST & AFRICA
10.4 TRAUMA MANAGEMENT
10.4.1 TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE
10.4.1.1 MECHANICAL HEMOSTASIS DEVICES
10.4.1.2 THERMAL DEVICES
10.4.1.3 TOPICAL AGENTS & INJECTABLES
10.4.1.4 OTHERS
10.4.2 TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
10.4.2.1 NORTH AMERICA
10.4.2.2 EUROPE
10.4.2.3 ASIA-PACIFIC
10.4.2.4 SOUTH AMERICA
10.4.2.5 MIDDLE EAST & AFRICA
10.5 OTHERS
10.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
10.5.1.1 NORTH AMERICA
10.5.1.2 EUROPE
10.5.1.3 ASIA-PACIFIC
10.5.1.4 SOUTH AMERICA
10.5.1.5 MIDDLE EAST & AFRICA
11 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.2.1 HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
11.2.1.1 PUBLIC
11.2.1.2 PRIVATE
11.2.2 HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
11.2.2.1 NORTH AMERICA
11.2.2.2 EUROPE
11.2.2.3 ASIA-PACIFIC
11.2.2.4 SOUTH AMERICA
11.2.2.5 MIDDLE EAST & AFRICA
11.3 AMBULATORY SURGERY CENTERS
11.3.1 AMBULATORY SURGERY CENTERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
11.3.1.1 NORTH AMERICA
11.3.1.2 EUROPE
11.3.1.3 ASIA-PACIFIC
11.3.1.4 SOUTH AMERICA
11.3.1.5 MIDDLE EAST & AFRICA
11.4 SPECIALTY CLINICS
11.4.1 SPECIALTY CLINICS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
11.4.1.1 NORTH AMERICA
11.4.1.2 EUROPE
11.4.1.3 ASIA-PACIFIC
11.4.1.4 SOUTH AMERICA
11.4.1.5 MIDDLE EAST & AFRICA
11.5 OTHERS
11.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
11.5.1.1 NORTH AMERICA
11.5.1.2 EUROPE
11.5.1.3 ASIA-PACIFIC
11.5.1.4 SOUTH AMERICA
11.5.1.5 MIDDLE EAST & AFRICA
12 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 INDIRECT SALES
12.2.1 INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE
12.2.1.1 OFFLINE
12.2.1.2 ONLINE
12.2.2 INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
12.2.2.1 NORTH AMERICA
12.2.2.2 EUROPE
12.2.2.3 ASIA-PACIFIC
12.2.2.4 SOUTH AMERICA
12.2.2.5 MIDDLE EAST & AFRICA
12.3 DIRECT SALES
12.3.1 DIRECT SALES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
12.3.1.1 NORTH AMERICA
12.3.1.2 EUROPE
12.3.1.3 ASIA-PACIFIC
12.3.1.4 SOUTH AMERICA
12.3.1.5 MIDDLE EAST & AFRICA
13 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
15 SWOT ANALYSIS
16 COMPANY PROFILES MANUFACTURERS
16.1 OLYMPUS CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 BOSTON SCIENTIFIC CORPORATION
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 CONMED CORPORATION
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 MEDTRONIC
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 COOK
16.5.1 COMPANY SNAPSHOT
16.5.2 COMPANY SHARE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 ANKAFERD
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVEOPMENT
16.7 B. BRAUN SE
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVEOPMENT
16.8 CREO MEDICAL GMBH
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 DIVERSATEK, INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVEOPMENT
16.1 DUOMED GROUP
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVEOPMENT
16.11 ENDOCLOT PLUS, INC.
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVEOPMENT
16.12 ERBE ELEKTROMEDIZIN GMBH
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 FUJIFILM HOLDINGS CORPORATION
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENT
16.14 JOHNSON & JOHNSON (ETHICON)
16.14.1 COMPANY SNAPSHOT
16.14.2 REVENUE ANALYSIS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVEOPMENT
16.15 KARL STORZ SE & CO. KG, TUTTLINGEN
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVEOPMENT
16.16 MEDITALIA S.R.L.
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 MICRO-TECH ENDOSCOPY
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 MTW ENDOSKOPIE MANUFAKTU
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVEOPMENT
16.19 OVESCO ENDOSCOPY AG
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVEOPMENT
16.2 PENTAX MEDICAL
16.20.1 COMPANY SNAPSHOT
16.20.2 SOLUTION PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 STERIS
16.21.1 COMPANY SNAPSHOT
16.21.2 REVENUE ANALYSIS
16.21.3 PRODUCT PORTFOLIO
16.21.4 RECENT DEVELOPMENT
17 COMPANY PROFILES DISTRIBUTOR
17.1 BOSTON IVY HEALTHCARE SOLUTIONS PRIVATE LIMITED
17.1.1 COMPANY SNAPSHOT
17.1.2 PRODUCT PORTFOLIO
17.1.3 RECENT DEVELOPMENT
17.2 CARDINAL HEALTH
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVEOPMENT
17.3 HENRY SCHEIN, INC.
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVEOPMENT
17.4 MCKESSON MEDICAL-SURGICAL INC.
17.4.1 COMPANY SNAPSHOT
17.4.2 PRODUCT PORTFOLIO
17.4.3 RECENT DEVEOPMENT
17.5 MFI MEDICAL
17.5.1 COMPANY SNAPSHOT
17.5.2 PRODUCT PORTFOLIO
17.5.3 RECENT DEVEOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2 NORTH AMERICA MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 3 NORTH AMERICA HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 4 NORTH AMERICA HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 5 NORTH AMERICA BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 6 NORTH AMERICA MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 7 NORTH AMERICA THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 8 NORTH AMERICA BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 9 NORTH AMERICA BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 10 NORTH AMERICA THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 11 NORTH AMERICA TOPICAL AGENTS & INJECTABLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 12 NORTH AMERICA TOPICAL AGENTS AND INJECTABLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 13 NORTH AMERICA OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 14 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 15 NORTH AMERICA UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 16 NORTH AMERICA UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 17 NORTH AMERICA LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 18 NORTH AMERICA LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 19 NORTH AMERICA BRONCHOSCOPIC HEMOSTASIS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 20 NORTH AMERICA OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 21 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 22 NORTH AMERICA GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 23 NORTH AMERICA GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 24 NORTH AMERICA GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 25 NORTH AMERICA NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 26 NORTH AMERICA NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 27 NORTH AMERICA NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 28 NORTH AMERICA TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 29 NORTH AMERICA TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 30 NORTH AMERICA OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 31 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 32 NORTH AMERICA HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 33 NORTH AMERICA HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 34 NORTH AMERICA AMBULATORY SURGERY CENTERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 35 NORTH AMERICA SPECIALTY CLINICS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 36 NORTH AMERICA OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 37 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 38 NORTH AMERICA INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 39 NORTH AMERICA INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 40 NORTH AMERICA DIRECT SALES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 41 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 42 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 43 NORTH AMERICA MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 44 NORTH AMERICA HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 45 NORTH AMERICA HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 46 NORTH AMERICA BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 47 NORTH AMERICA THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 48 NORTH AMERICA BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 49 NORTH AMERICA BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 50 NORTH AMERICA TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 51 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 52 NORTH AMERICA UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 53 NORTH AMERICA LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 54 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 55 NORTH AMERICA GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 56 NORTH AMERICA GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 57 NORTH AMERICA NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 58 NORTH AMERICA NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 59 NORTH AMERICA TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 60 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 61 NORTH AMERICA HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 62 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 63 NORTH AMERICA INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 64 U.S. ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 65 U.S. MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 66 U.S. HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 67 U.S. HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 68 U.S. BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 69 U.S. THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 70 U.S. BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 71 U.S. BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 72 U.S. TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 73 U.S. ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 74 U.S. UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 75 U.S. LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 76 U.S. ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 77 U.S. GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 78 U.S. GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 79 U.S. NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 80 U.S. NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 81 U.S. TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 82 U.S. ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 83 U.S. HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 84 U.S. ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 85 U.S. INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 86 CANADA ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 87 CANADA MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 88 CANADA HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 89 CANADA HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 90 CANADA BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 91 CANADA THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 92 CANADA BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 93 CANADA BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 94 CANADA TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 95 CANADA ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 96 CANADA UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 97 CANADA LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 98 CANADA ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 99 CANADA GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 100 CANADA GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 101 CANADA NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 102 CANADA NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 103 CANADA TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 104 CANADA ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 105 CANADA HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 106 CANADA ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 107 CANADA INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 108 MEXICO ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 109 MEXICO MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 110 MEXICO HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 111 MEXICO HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 112 MEXICO BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 113 MEXICO THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 114 MEXICO BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 115 MEXICO BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 116 MEXICO TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 117 MEXICO ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 118 MEXICO UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 119 MEXICO LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 120 MEXICO ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 121 MEXICO GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 122 MEXICO GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 123 MEXICO NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 124 MEXICO NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 125 MEXICO TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 126 MEXICO ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 127 MEXICO HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 128 MEXICO ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 129 MEXICO INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
List of Figure
FIGURE 1 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: COUNTRYWISE MARKET ANALYSIS
FIGURE 5 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: MULTIVARIATE MODELLING
FIGURE 8 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: MARKET END-USER COVERAGE GRID
FIGURE 11 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: SEGMENTATION
FIGURE 12 TWO SEGMENTS COMPRISE THE DOMINICAN REPUBLIC ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE
FIGURE 13 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: EXECUTIVE SUMMARY
FIGURE 14 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: STRATEGIC DECISIONS
FIGURE 15 RISING PREVALANCE OF ENDOSCOPIC HEMOSTASIS CASES EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET FROM 2026 TO 2033
FIGURE 16 THE TYPE 2 ENDOSCOPIC HEMOSTASIS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET IN 2026 & 2033
FIGURE 17 COMPANY EVALUATION QUADRANT
FIGURE 18 DROC ANALYSIS
FIGURE 19 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2025
FIGURE 20 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: BY PRODUCT TYPE , CAGR (2025-2032)
FIGURE 21 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: BY PRODUCT TYPE , CAGR (2025-2032)
FIGURE 22 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: BY PRODUCT TYPE , LIFELINE CURVE (2025-2032)
FIGURE 23 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE TYPE, 2025
FIGURE 24 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: BY PROCEDURE , 2026-2033 (USD THOUSAND)
FIGURE 25 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: BY PROCEDURE , 2026-2033 (USD THOUSAND)
FIGURE 26 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2025
FIGURE 27 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: BY APPLICATION, 2026-2033 (USD THOUSAND)
FIGURE 28 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: BY APPLICATION, 2026-2033 (USD THOUSAND)
FIGURE 29 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: BY APPLICATION, 2026-2033 (USD THOUSAND)
FIGURE 30 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2025
FIGURE 31 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: BY END USER, 2026-2033 (USD THOUSAND)
FIGURE 32 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: BY END USER, 2026-2033 (USD THOUSAND)
FIGURE 33 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: BY END USER, 2026-2033 (USD THOUSAND)
FIGURE 34 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2025
FIGURE 35 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: BY DISTRIBUTION CHANNEL, 2026-2033 (USD THOUSAND)
FIGURE 36 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: BY DISTRIBUTION CHANNEL, 2026-2033 (USD THOUSAND)
FIGURE 37 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: BY DISTRIBUTION CHANNEL, 2026-2033 (USD THOUSAND)
FIGURE 38 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: SNAPSHOT (2025)
FIGURE 39 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: COMPANY SHARE 2025 (%)
